Archived Newsletters

  1. 06.30.25 -- STREAM Edition: When Outsourcing, Take Advantage Of Each Other's Strengths 6/30/2025

    06/30/25 Outsourced Pharma Newsletter

  2. 06.30.25 -- Lonza Bets The House On Biologics. What's It Mean For You? 6/30/2025
    06/30/25 Outsourced Pharma Newsletter
  3. 06.27.25 -- How A Biotech Navigates The CDMO Frenzy For GLP-1 Services 6/27/2025
    06/27/25 Outsourced Pharma Newsletter
  4. 06.26.25 -- Outsourcing GLP-1 Programs: Is There Capacity For Biotechs? 6/26/2025
    06/26/25 Outsourced Pharma Newsletter
  5. 06.25.25 -- Technical Approaches To Strengthen Your Drug Product Development 6/25/2025

    06/25/25 Outsourced Pharma Newsletter

  6. 06.25.25 -- Streamline Your Scale-Up: Key Strategies For Biologics Manufacturing Success 6/25/2025

    06/25/25 Outsourced Pharma Newsletter

  7. 06.25.25 -- Early-Phase Formulation Done Right: An Expert Analysis 6/25/2025
    06/25/25 Outsourced Pharma Newsletter
  8. 06.24.25 -- A Psychedelic Path To CDMO Selection? 6/24/2025
    06/24/25 Outsourced Pharma Newsletter
  9. 06.23.25 -- STREAM Edition: Drug Development Outsourcing: The Devil Is In The Details 6/23/2025

    06/23/25 Outsourced Pharma Newsletter

  10. 06.23.25 -- Is An Outsourced BD Model Gaining Traction At CDMOs? 6/23/2025
    06/23/25 Outsourced Pharma Newsletter